In a filing, Allstate Corp revealed its President,Enterprise Solutions Gupta Suren unloaded Company’s shares for reported $4.11 million on Jan 07 ’26. In the deal valued at $210.00 per share,19,593 shares were sold. As a result of this transaction, Gupta Suren now holds 100,646 shares worth roughly $21.0 million.
Then, Gupta Suren bought 19,593 shares, generating $4,114,530 in total proceeds.
Before that, WILSON THOMAS J sold 16,807 shares. Allstate Corp shares valued at $3,441,632 were divested by the Chairman, President & CEO at a price of $204.77 per share. As a result of the transaction, WILSON THOMAS J now holds 111,215 shares, worth roughly $23.21 million.
TD Cowen downgraded its Allstate Corp [ALL] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including William Blair’s analysts, who decreased its forecast for the stock in mid December from “an Outperform” to “a Mkt perform”. Morgan Stanley also remained covering ALL and has decreased its forecast on December 16, 2025 with a “an Equal-weight” recommendation from previously “an Overweight” rating. Evercore ISI revised its rating on October 01, 2025. It rated ALL as “an In-line” which previously was an “an Outperform”.
Price Performance Review of ALL
On Monday, Allstate Corp [NYSE:ALL] saw its stock fall -1.67% to $208.66. Over the last five days, the stock has gained 1.50%. Allstate Corp shares have risen nearly 8.79% since the year began. Nevertheless, the stocks have risen 0.25% over the past one year.
How much short interest is there in Allstate Corp?
A steep rise in short interest was recorded in Allstate Corp stocks on 2025-12-31, growing by 0.48 million shares to a total of 4.75 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 4.27 million shares. There was a rise of 10.06%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 16, 2025 when Wolfe Research began covering the stock and recommended ‘”an Outperform”‘ rating along with a $235 price target.
